Home › Funds › LOCKHEED MARTIN INVESTMENT MANAGEMENT CO › ABBV

LOCKHEED MARTIN INVESTMENT MANAGEMENT CO position in ABBV

ABBVIE INC · Health Care

LOCKHEED MARTIN INVESTMENT MANAGEMENT CO reported holding 28,160 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$7.4M, representing 0.52% of its reported portfolio and ranking #40 among its reported holdings. LOCKHEED MARTIN INVESTMENT MANAGEMENT CO has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)28.16K sh
Reported value held$7.37M
Portfolio Weight0.52%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LOCKHEED MARTIN INVESTMENT MANAGEMENT CO's ABBV position evolved

LOCKHEED MARTIN INVESTMENT MANAGEMENT CO first disclosed a stake in ABBV in Q3 2023 at 65,650 shares (US$9.7M). The position peaked in Q3 2024 at 71,690 shares, worth US$14.2M. Across 13 filings, LOCKHEED MARTIN INVESTMENT MANAGEMENT CO increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 28,160 shares valued at US$7.4M — a reduction of -12,970 shares quarter over quarter.. Notable position changes include a 38% increase in Q3 2024 (shares fell 9% over the following quarter), a 58% increase in Q2 2025 (shares rose 26% over the following quarter), a 43% trim in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 65.65K $9.66M New
Q4 2023 65.65K $9.87M Hold
Q1 2024 44.77K $7.42M Reduce
Q2 2024 52.12K $8.94M Add
Q3 2024 71.69K $14.16M Add
Q4 2024 46.32K $8.23M Reduce
Q1 2025 44.67K $9.36M Reduce
Q2 2025 70.70K $13.12M Add
Q3 2025 40.31K $9.33M Reduce
Q4 2025 45.14K $10.31M Add
Q1 2026 45.61K $9.92M Add
Q2 2026 41.13K $10.35M Reduce
Q3 2026 28.16K $7.37M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has LOCKHEED MARTIN INVESTMENT MANAGEMENT CO held ABBV?

LOCKHEED MARTIN INVESTMENT MANAGEMENT CO has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LOCKHEED MARTIN INVESTMENT MANAGEMENT CO's current position in ABBV?

As of Q3 2026, LOCKHEED MARTIN INVESTMENT MANAGEMENT CO holds 28.16K shares of ABBV (ABBVIE INC), valued at $7.37M, representing 0.52% of its reported portfolio and ranking #40.

Has LOCKHEED MARTIN INVESTMENT MANAGEMENT CO been buying or selling ABBV?

In the latest 13F filing (Q3 2026), LOCKHEED MARTIN INVESTMENT MANAGEMENT CO reduced its position in ABBV. The position peaked in Q3 2024 at 71.69K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.